Mineralys Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $12.59-$47.65 |
Market Cap | $2.1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.29 |
News
See moreYahoo Finance • 7 days ago
Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock?
Yahoo Finance • 14 days ago
Immunic appoints biopharmaceutical executive Jon Congleton to board
Yahoo Finance • last month
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Yahoo Finance • 2 months ago
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Jon Congleton |
CFO | Mr. Adam Scott Levy |
Address | 150 N. Radnor Chester Road, Radnor, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |
